Pharming Average Inventory from 2010 to 2025

PHAR Stock  USD 8.68  0.14  1.64%   
Pharming Group Average Inventory yearly trend continues to be relatively stable with very little volatility. Average Inventory is likely to drop to about 11.8 M. Average Inventory is the average amount of inventory Pharming Group NV holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. View All Fundamentals
 
Average Inventory  
First Reported
2010-12-31
Previous Quarter
21.8 M
Current Value
11.8 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 6.4 M or Selling And Marketing Expenses of 7.4 M, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 3.92. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
  
Check out the analysis of Pharming Group Correlation against competitors.

Latest Pharming Group's Average Inventory Growth Pattern

Below is the plot of the Average Inventory of Pharming Group NV over the last few years. It is the average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. Pharming Group's Average Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
Average Inventory10 Years Trend
Slightly volatile
   Average Inventory   
       Timeline  

Pharming Average Inventory Regression Statistics

Arithmetic Mean17,079,986
Geometric Mean15,177,442
Coefficient Of Variation40.85
Mean Deviation5,718,463
Median20,901,012
Standard Deviation6,977,261
Sample Variance48.7T
Range19.6M
R-Value0.67
Mean Square Error28.5T
R-Squared0.45
Significance0
Slope987,679
Total Sum of Squares730.2T

Pharming Average Inventory History

202511.8 M
202421.8 M
202024.2 M
201918 M
201620.9 M
201417 M

About Pharming Group Financial Statements

Pharming Group shareholders use historical fundamental indicators, such as Average Inventory, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. The changes in Pharming Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharming Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Average Inventory21.8 M11.8 M

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.